用生物活性化合物优化线粒体向:慢性病患者的饮食模式考虑
Valeria Cecchini1, Dario Troise2, Alice Sabatino1
1Division of Renal Medicine, Baxter Novum. Department of Clinical Science, Intervention and Technology. Karolinska Institutet, Sweden.
概括
线粒体功能障碍是慢性病 (CKD) 的关键. 富含生物活性化合物的植物性饮食可以恢复线粒体功能并改善健康.
科学领域:
- 肝脏病学
- 线粒体生物学
- 营养科学
背景情况:
- 线粒体功能障碍是慢性病 (CKD) 发展和进展的核心因素.
- 它与关键的病理过程有关,包括炎症,氧化应激和细胞衰老.
- 恢复线粒体功能是延缓CKD进展和管理尿素症状的潜在治疗策略.
研究的目的:
- 探索生物活性化合物对抗线粒体功能障碍的作用.
- 研究饮食模式在提供这些化合物的细胞健康方面的潜力.
- 通过营养干预,突出植物性饮食在治疗慢性病中的重要性.
主要方法:
- 对CKD中线粒体功能障碍的当前文献的综述.
- 对饮食中的生物活性化合物 (植物营养素,omega-3脂肪酸) 在细胞健康中的作用的分析.
- 评估支持饮食模式而非单独营养的证据.
主要成果:
- 在食物中发现的生物活性化合物,包括植物营养素和omega-3脂肪酸,在支持细胞健康方面具有前景.
- 这些化合物可以抵消线粒体功能障碍,降低慢性疾病风险,调节新陈代谢.
- 植物性饮食模式富含这些有益的化合物.
结论:
- 基于植物的饮食模式是利用生物活性化合物来支持CKD中的线粒体功能的一个有希望的策略.
- 聚焦全食和植物性模式的饮食干预措施可能对脏健康有显著的益处.
- 将营养科学转化为实际的饮食建议对于有效管理慢性病至关重要.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Chronic Kidney Disease IV: Nursing Management
54
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
54
Chronic Kidney Disease I: Introduction
65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease II: Clinical Manifestations
85
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85
Renal Failure: Dose Adjustments
152
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
152


